Today news
About the same in other media
CG Oncology valued at $1.75 billion in strong market debut
Reading now: 606
(Reuters) -Cancer drug developer CG Oncology notched up a valuation of $1.75 billion in its market debut on Thursday, after its shares jumped 52.6% at the open, as demand for new listings pick up after a two-year dry spell.
The IPO market is looking for a turnaround in fortunes as bets of a soft-landing for the U.S. economy rise, after two sub-par years fueled by the Federal Reserve's aggressive interest rate hikes and geopolitical pressures.
The Irvine, California-based company debuted at $29 per share on the Nasdaq, above the upsized offer price of $19 apiece. The firm sold 20 million shares in its offering and raised $380 million.
Read more on investing.comAbout this in other media
$WEN Sheds More Than Half Its Value as $GFOX Hype Grows Stronger cryptonews.com /8 months ago
Market cap of four most valued firms jumps ₹2.18 lakh crore; LIC, SBI lead gainers livemint.com /8 months ago
UN experts investigating 58 suspected North Korean cyberattacks valued at about USD 3 billion economictimes.indiatimes.com /8 months ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
